Prasugrel Versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis of Randomized Trials
ConclusionIn patients with ACS undergoing PCI, both prasugrel and ticagrelor were associated with similar cardiovascular outcomes and adverse bleeding events.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Academia | Angioplasty | Aspirin | Bleeding | Cardiology | Cardiovascular | Coronary Angioplasty | Heart | Heart Attack | Percutaneous Coronary Intervention | Stroke | Thrombosis